Home Healthcare IT Neurodegenerative Disease Market Size, Demand, Forecast to 2030

Neurodegenerative Disease Market

Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy (SMA) , Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Acetylcholinesterase (AChE) Inhibitors, Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitor, SSRIs, Other Drug Types) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI1582DR
Study Period 2018-2030 CAGR 3.2%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD 40,125 Million
Forecast Year 2030 Forecast Year Market Size USD 53275 Million
Largest Market North America Fastest Growing Market Europe
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Neurodegenerative Disease Market, By Indication Type (2020-2030)
    1. Parkinson's Disease
    2. Alzheimer's Disease
    3. Multiple Sclerosis
    4. Huntington Disease
    5. Amyotrophic Lateral Sclerosis
    6. Spinal Muscular Atrophy (SMA) 
    7. Other Indication Types
  2. Neurodegenerative Disease Market, By Drug Type (2020-2030)
    1. N-methyl-D-aspartate Receptor antagonists
    2. Cholinesterase Inhibitors
    3. Dopamine Agonists
    4. Immunomodulatory Drugs
    5. Acetylcholinesterase (AChE) Inhibitors
    6. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
    7. Catechol-O-Methyltransferase (COMT) Inhibitor
    8. SSRIs
    9. Other Drug Types
    1. North America
      1. North America Neurodegenerative Disease Market, By Indication Type
        1. Parkinson's Disease
          1. Alzheimer's Disease
            1. Multiple Sclerosis
              1. Huntington Disease
                1. Amyotrophic Lateral Sclerosis
                  1. Spinal Muscular Atrophy (SMA) 
                    1. Other Indication Types
                    2. North America Neurodegenerative Disease Market, By Drug Type
                      1. N-methyl-D-aspartate Receptor antagonists
                        1. Cholinesterase Inhibitors
                          1. Dopamine Agonists
                            1. Immunomodulatory Drugs
                              1. Acetylcholinesterase (AChE) Inhibitors
                                1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                  1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                    1. SSRIs
                                      1. Other Drug Types
                                      2. U.S.
                                        1. U.S. Neurodegenerative Disease Market, By Indication Type
                                          1. Parkinson's Disease
                                            1. Alzheimer's Disease
                                              1. Multiple Sclerosis
                                                1. Huntington Disease
                                                  1. Amyotrophic Lateral Sclerosis
                                                    1. Spinal Muscular Atrophy (SMA) 
                                                      1. Other Indication Types
                                                      2. U.S. Neurodegenerative Disease Market, By Drug Type
                                                        1. N-methyl-D-aspartate Receptor antagonists
                                                          1. Cholinesterase Inhibitors
                                                            1. Dopamine Agonists
                                                              1. Immunomodulatory Drugs
                                                                1. Acetylcholinesterase (AChE) Inhibitors
                                                                  1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                    1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                      1. SSRIs
                                                                        1. Other Drug Types
                                                                      2. Canada
                                                                    2. Europe
                                                                      1. Europe Neurodegenerative Disease Market, By Indication Type
                                                                        1. Parkinson's Disease
                                                                          1. Alzheimer's Disease
                                                                            1. Multiple Sclerosis
                                                                              1. Huntington Disease
                                                                                1. Amyotrophic Lateral Sclerosis
                                                                                  1. Spinal Muscular Atrophy (SMA) 
                                                                                    1. Other Indication Types
                                                                                    2. Europe Neurodegenerative Disease Market, By Drug Type
                                                                                      1. N-methyl-D-aspartate Receptor antagonists
                                                                                        1. Cholinesterase Inhibitors
                                                                                          1. Dopamine Agonists
                                                                                            1. Immunomodulatory Drugs
                                                                                              1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                  1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                    1. SSRIs
                                                                                                      1. Other Drug Types
                                                                                                      2. U.K.
                                                                                                        1. U.K. Neurodegenerative Disease Market, By Indication Type
                                                                                                          1. Parkinson's Disease
                                                                                                            1. Alzheimer's Disease
                                                                                                              1. Multiple Sclerosis
                                                                                                                1. Huntington Disease
                                                                                                                  1. Amyotrophic Lateral Sclerosis
                                                                                                                    1. Spinal Muscular Atrophy (SMA) 
                                                                                                                      1. Other Indication Types
                                                                                                                      2. U.K. Neurodegenerative Disease Market, By Drug Type
                                                                                                                        1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                          1. Cholinesterase Inhibitors
                                                                                                                            1. Dopamine Agonists
                                                                                                                              1. Immunomodulatory Drugs
                                                                                                                                1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                  1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                    1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                      1. SSRIs
                                                                                                                                        1. Other Drug Types
                                                                                                                                      2. Germany
                                                                                                                                      3. France
                                                                                                                                      4. Spain
                                                                                                                                      5. Italy
                                                                                                                                      6. Russia
                                                                                                                                      7. Nordic
                                                                                                                                      8. Benelux
                                                                                                                                      9. Rest of Europe
                                                                                                                                    2. APAC
                                                                                                                                      1. APAC Neurodegenerative Disease Market, By Indication Type
                                                                                                                                        1. Parkinson's Disease
                                                                                                                                          1. Alzheimer's Disease
                                                                                                                                            1. Multiple Sclerosis
                                                                                                                                              1. Huntington Disease
                                                                                                                                                1. Amyotrophic Lateral Sclerosis
                                                                                                                                                  1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                    1. Other Indication Types
                                                                                                                                                    2. APAC Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                      1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                        1. Cholinesterase Inhibitors
                                                                                                                                                          1. Dopamine Agonists
                                                                                                                                                            1. Immunomodulatory Drugs
                                                                                                                                                              1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                  1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                    1. SSRIs
                                                                                                                                                                      1. Other Drug Types
                                                                                                                                                                      2. China
                                                                                                                                                                        1. China Neurodegenerative Disease Market, By Indication Type
                                                                                                                                                                          1. Parkinson's Disease
                                                                                                                                                                            1. Alzheimer's Disease
                                                                                                                                                                              1. Multiple Sclerosis
                                                                                                                                                                                1. Huntington Disease
                                                                                                                                                                                  1. Amyotrophic Lateral Sclerosis
                                                                                                                                                                                    1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                                                      1. Other Indication Types
                                                                                                                                                                                      2. China Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                        1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                                                          1. Cholinesterase Inhibitors
                                                                                                                                                                                            1. Dopamine Agonists
                                                                                                                                                                                              1. Immunomodulatory Drugs
                                                                                                                                                                                                1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                                                  1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                                                    1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                                                      1. SSRIs
                                                                                                                                                                                                        1. Other Drug Types
                                                                                                                                                                                                      2. Korea
                                                                                                                                                                                                      3. Japan
                                                                                                                                                                                                      4. India
                                                                                                                                                                                                      5. Australia
                                                                                                                                                                                                      6. Taiwan
                                                                                                                                                                                                      7. South East Asia
                                                                                                                                                                                                      8. Rest of Asia-Pacific
                                                                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                                                                      1. Middle East and Africa Neurodegenerative Disease Market, By Indication Type
                                                                                                                                                                                                        1. Parkinson's Disease
                                                                                                                                                                                                          1. Alzheimer's Disease
                                                                                                                                                                                                            1. Multiple Sclerosis
                                                                                                                                                                                                              1. Huntington Disease
                                                                                                                                                                                                                1. Amyotrophic Lateral Sclerosis
                                                                                                                                                                                                                  1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                                                                                    1. Other Indication Types
                                                                                                                                                                                                                    2. Middle East and Africa Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                                                      1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                                                                                        1. Cholinesterase Inhibitors
                                                                                                                                                                                                                          1. Dopamine Agonists
                                                                                                                                                                                                                            1. Immunomodulatory Drugs
                                                                                                                                                                                                                              1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                                                                                1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                                                                                  1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                                                                                    1. SSRIs
                                                                                                                                                                                                                                      1. Other Drug Types
                                                                                                                                                                                                                                      2. UAE
                                                                                                                                                                                                                                        1. UAE Neurodegenerative Disease Market, By Indication Type
                                                                                                                                                                                                                                          1. Parkinson's Disease
                                                                                                                                                                                                                                            1. Alzheimer's Disease
                                                                                                                                                                                                                                              1. Multiple Sclerosis
                                                                                                                                                                                                                                                1. Huntington Disease
                                                                                                                                                                                                                                                  1. Amyotrophic Lateral Sclerosis
                                                                                                                                                                                                                                                    1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                                                                                                                      1. Other Indication Types
                                                                                                                                                                                                                                                      2. UAE Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                                                                                        1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                                                                                                                          1. Cholinesterase Inhibitors
                                                                                                                                                                                                                                                            1. Dopamine Agonists
                                                                                                                                                                                                                                                              1. Immunomodulatory Drugs
                                                                                                                                                                                                                                                                1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                                                                                                                  1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                                                                                                                    1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                                                                                                                      1. SSRIs
                                                                                                                                                                                                                                                                        1. Other Drug Types
                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                      1. LATAM Neurodegenerative Disease Market, By Indication Type
                                                                                                                                                                                                                                                                        1. Parkinson's Disease
                                                                                                                                                                                                                                                                          1. Alzheimer's Disease
                                                                                                                                                                                                                                                                            1. Multiple Sclerosis
                                                                                                                                                                                                                                                                              1. Huntington Disease
                                                                                                                                                                                                                                                                                1. Amyotrophic Lateral Sclerosis
                                                                                                                                                                                                                                                                                  1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                                                                                                                                                    1. Other Indication Types
                                                                                                                                                                                                                                                                                    2. LATAM Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                                                                                                                      1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                                                                                                                                                        1. Cholinesterase Inhibitors
                                                                                                                                                                                                                                                                                          1. Dopamine Agonists
                                                                                                                                                                                                                                                                                            1. Immunomodulatory Drugs
                                                                                                                                                                                                                                                                                              1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                                                                                                                                                1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                                                                                                                                                  1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                                                                                                                                                    1. SSRIs
                                                                                                                                                                                                                                                                                                      1. Other Drug Types
                                                                                                                                                                                                                                                                                                      2. Brazil
                                                                                                                                                                                                                                                                                                        1. Brazil Neurodegenerative Disease Market, By Indication Type
                                                                                                                                                                                                                                                                                                          1. Parkinson's Disease
                                                                                                                                                                                                                                                                                                            1. Alzheimer's Disease
                                                                                                                                                                                                                                                                                                              1. Multiple Sclerosis
                                                                                                                                                                                                                                                                                                                1. Huntington Disease
                                                                                                                                                                                                                                                                                                                  1. Amyotrophic Lateral Sclerosis
                                                                                                                                                                                                                                                                                                                    1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                                                                                                                                                                                      1. Other Indication Types
                                                                                                                                                                                                                                                                                                                      2. Brazil Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                                                                                                                                                        1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                                                                                                                                                                                          1. Cholinesterase Inhibitors
                                                                                                                                                                                                                                                                                                                            1. Dopamine Agonists
                                                                                                                                                                                                                                                                                                                              1. Immunomodulatory Drugs
                                                                                                                                                                                                                                                                                                                                1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                                                                                                                                                                                  1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                                                                                                                                                                                    1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                                                                                                                                                                                      1. SSRIs
                                                                                                                                                                                                                                                                                                                                        1. Other Drug Types
                                                                                                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                  Related Reports

                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  The global regenerative medicine market size was valued at USD 13.4 Billion in 2022. It is expected to reach USD 72.2 Billion by 2031, growing at a CAGR of 17.6% during the forecast period (2023–2031). Regenerative medications are us
                                                                                                                                                                                                                                                                                                                                  Buy Now

                                                                                                                                                                                                                                                                                                                                  Purchase Benefits

                                                                                                                                                                                                                                                                                                                                  • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                  • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                  • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                  • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                  • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                  • Permission to print the report


                                                                                                                                                                                                                                                                                                                                  We are featured on :